BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21518997)

  • 1. Cerebral blood flow by arterial spin labeling in poststroke dementia.
    Firbank MJ; He J; Blamire AM; Singh B; Danson P; Kalaria RN; O'Brien JT
    Neurology; 2011 Apr; 76(17):1478-84. PubMed ID: 21518997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging.
    Schuff N; Matsumoto S; Kmiecik J; Studholme C; Du A; Ezekiel F; Miller BL; Kramer JH; Jagust WJ; Chui HC; Weiner MW
    Alzheimers Dement; 2009 Nov; 5(6):454-62. PubMed ID: 19896584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron volumes in hippocampal subfields in delayed poststroke and aging-related dementias.
    Gemmell E; Tam E; Allan L; Hall R; Khundakar A; Oakley AE; Thomas A; Deramecourt V; Kalaria RN
    J Neuropathol Exp Neurol; 2014 Apr; 73(4):305-11. PubMed ID: 24607963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-continuous arterial spin labeling quantifies cerebral blood flow in patients with acute ischemic stroke and chronic lacunar stroke.
    Guo L; Zhang Q; Ding L; Liu K; Ding K; Jiang C; Liu C; Li K; Cui L
    Clin Neurol Neurosurg; 2014 Oct; 125():229-36. PubMed ID: 25203634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.
    Bangen KJ; Restom K; Liu TT; Wierenga CE; Jak AJ; Salmon DP; Bondi MW
    J Alzheimers Dis; 2012; 31 Suppl 3(0):S59-74. PubMed ID: 22531427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
    J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Midlife Cardiovascular Risk Profiles With Cerebral Perfusion at Older Ages.
    Suri S; Topiwala A; Chappell MA; Okell TW; Zsoldos E; Singh-Manoux A; Kivimäki M; Mackay CE; Ebmeier KP
    JAMA Netw Open; 2019 Jun; 2(6):e195776. PubMed ID: 31225888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
    Du AT; Jahng GH; Hayasaka S; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin KP; Miller BL; Weiner MW; Schuff N
    Neurology; 2006 Oct; 67(7):1215-20. PubMed ID: 17030755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.
    Yoshikawa T; Murase K; Oku N; Imaizumi M; Takasawa M; Rishu P; Kimura Y; Ikejiri Y; Kitagawa K; Hori M; Hatazawa J
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1341-7. PubMed ID: 12917125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional cerebral blood flow and cerebrovascular reactivity in Alzheimer's disease and vascular dementia assessed by arterial spinlabeling magnetic resonance imaging.
    Gao YZ; Zhang JJ; Liu H; Wu GY; Xiong L; Shu M
    Curr Neurovasc Res; 2013 Feb; 10(1):49-53. PubMed ID: 23151075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling.
    Wang T; Li Y; Guo X; Huang D; Ma L; Wang DJ; Lou X
    J Magn Reson Imaging; 2016 Mar; 43(3):635-43. PubMed ID: 26256700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
    Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated removal of spurious intermediate cerebral blood flow volumes improves image quality among older patients: A clinical arterial spin labeling investigation.
    Shirzadi Z; Crane DE; Robertson AD; Maralani PJ; Aviv RI; Chappell MA; Goldstein BI; Black SE; MacIntosh BJ
    J Magn Reson Imaging; 2015 Nov; 42(5):1377-85. PubMed ID: 25873287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease.
    Zlatar ZZ; Wierenga CE; Bangen KJ; Liu TT; Jak AJ
    J Alzheimers Dis; 2014; 41(3):809-17. PubMed ID: 24685629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.